Startseite › Brustkrebs › Virginia › Richmond
Klinische Studien zu Brustkrebs in Richmond, VA
26 Studien zu Brustkrebs suchen Teilnehmer an Standorten in und um Richmond (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Teilnehmer gesuchtPhase 3
- Bon Secours Virginia Health System, Midlothian · 11 mi entfernt
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- und 3 weitere
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- Virginia Cancer Institute, Richmond
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Teilnehmer gesuchtPhase 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11 mi entfernt
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Teilnehmer gesuchtPhase 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · 11 mi entfernt
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Teilnehmer gesuchtPhase 3
- Research Site, Midlothian · 11 mi entfernt
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Clinical Trial Site, Midlothian · 11 mi entfernt
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Teilnehmer gesucht
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Teilnehmer gesuchtPhase 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · 6 mi entfernt
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi entfernt
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Teilnehmer gesuchtPhase 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Research Site, Midlothian · 11 mi entfernt
The Vanguard Study: Testing a New Way to Screen for Cancer
Teilnehmer gesuchtGesunde Freiwillige willkommen
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Teilnehmer gesuchtPhase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- und 4 weitere
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Teilnehmer gesuchtPhase 2/3
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi entfernt
E-Mindfulness Approaches for Living After Breast Cancer
Teilnehmer gesuchtPhase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- und 4 weitere
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Teilnehmer gesucht
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Teilnehmer gesuchtPhase 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Teilnehmer gesuchtPhase 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Teilnehmer gesuchtPhase 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · 11 mi entfernt
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Teilnehmer gesuchtPhase 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · 6 mi entfernt
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Teilnehmer gesuchtPhase 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · 6 mi entfernt
- und 1 weitere
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Teilnehmer gesuchtBeobachtungsstudie
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Teilnehmer gesuchtBeobachtungsstudie
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Teilnehmer gesuchtBeobachtungsstudie
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · 11 mi entfernt
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Teilnehmer gesuchtPhase 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Virginia Commonwealth University, Richmond
Brustkrebs-Studien in anderen Städten
- New York City, NY134 Studien
- Houston, TX126 Studien
- Boston, MA111 Studien
- Nashville, TN80 Studien
- Los Angeles, CA72 Studien
- Edison, NJ68 Studien
- St. Louis, MO64 Studien
- Durham, NC63 Studien
- Queens, NY63 Studien
- Chicago, IL58 Studien
- Philadelphia, PA56 Studien
- Dallas, TX55 Studien
Weitere Studien in Richmond
- Nichtkleinzelliges Lungenkarzinom25 Studien
- Prostatakrebs19 Studien
- Herzinsuffizienz16 Studien
- Lungenkrebs14 Studien
- Kolorektales Karzinom13 Studien
- Herz-Kreislauf-Erkrankungen13 Studien
- Steatose der Leber12 Studien
- Akute myeloische Leukämie12 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich12 Studien
- Metastasierender Krebs12 Studien
- Melanom11 Studien
- Adipositas11 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.